Submit Deal

PIPER HEARTLAND HEALTHCARE CAPITAL

HQ - Minneapolis

Summary

Piper Heartland Healthcare Capital is a buyout fund managed by Piper Sandler. The fund targets to invest in healthcare sector.

Deals Overview

Total Deals13

Valued Deals13

Total Value£ 1.41 B

Avg. Deal Size£ 108 M

Market Context

Senior Management

Matt Hemsley
CEO

Sort

27 Jul 2021|United Kingdom|Biotechnology

Target: ARTIOS PHARMA LIMITED

Bidder: SOLEUS CAPITAL

12 Service Providers

2 Target | 10 Bidder

13 Dealmakers

3 Target | 10 Bidder

£ 110 M

Value

09 Nov 2021|United States|Pharmaceuticals

Target: ARBOR BIOTHECHNOLOGIES

Bidder: TCG CROSSOVER

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 159 M

Value

02 Nov 2021|United States|Biotechnology

Target: SHORELINE BIOSCIENCES

Bidder: EVENTIDE ASSET MANAGEMENT

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 102 M

Value

07 Feb 2022|United States|Biotechnology

Target: ENDEAVOR BIOMEDICINES

Bidder: ALLY BRIDGE GROUP

10 Service Providers

2 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 74 M

Value

06 Mar 2023|United States|Biotechnology

Target: BICARA THERAPEUTICS

Bidder: PREMJI INVEST

15 Service Providers

3 Target | 12 Bidder

14 Dealmakers

3 Target | 11 Bidder

£ 89 M

Value

16 May 2023|United States|Biotechnology

Target: BOUNDLESS BIO

Bidder: LEAPS BY BAYER

15 Service Providers

2 Target | 13 Bidder

16 Dealmakers

3 Target | 13 Bidder

£ 80 M

Value

01 Mar 2023|United States|Biotechnology

Target: CARGO THERAPEUTICS

Bidder: THIRD ROCK VENTURES LLC

4 Service Providers

2 Target | 2 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 157 M

Value

13 Feb 2024|United States|Biotechnology

Target: PROFOUNDBIO

Bidder: JANUS HENDERSON INVESTORS

3 Service Providers

2 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 88 M

Value

06 Mar 2024|United States|Biotechnology

Target: ALUMIS

Bidder: CORMORANT ASSET MANAGEMENT

6 Service Providers

3 Target | 3 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 204 M

Value

24 Apr 2024|United States|Biotechnology

Target: ENDEAVOR BIOMEDICINES

Bidder: AYURMAYA CAPITAL

4 Service Providers

3 Target | 1 Bidder

4 Dealmakers

3 Target | 1 Bidder

£ 106 M

Value

22 Oct 2024|United States|Biotechnology

Target: AVENCELL THERAPEUTICS

Bidder: NYBC VENTURES

4 Service Providers

2 Target | 2 Bidder

8 Dealmakers

6 Target | 2 Bidder

£ 86 M

Value

03 Dec 2024|United States|Biotechnology

Target: MAZE THERAPEUTICS

Bidder: JANUS HENDERSON INVESTORS

6 Service Providers

3 Target | 3 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 90 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy